Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
A phase 3 trial of Capecitabine, Floxuridine and Oxaliplatin in Colorectal cancer and Metastatic cancer, run by NSABP Foundation Inc, recorded as terminated on the registry.
Overview
Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer is a phase 3 interventional study registered as NCT00268463 by NSABP Foundation Inc, with 22 participants recorded, started 2006-01 and due to reach its primary completion in 2008-06. Interventions recorded: capecitabine, floxuridine, oxaliplatin. Conditions recorded: Colorectal Cancer, Metastatic Cancer.
Linked to the drug Floxuridine because the registry names it among its interventions and Colorectal cancer and Metastatic cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialFUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM
Shares Floxuridine, Oxaliplatin, Colorectal cancer and the tag pipeline.
- TrialEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Shares Oxaliplatin, Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialSOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients
Shares Oxaliplatin, Capecitabine, Colorectal cancer and the tag pipeline.
- TrialA Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
Shares Oxaliplatin, Capecitabine, Colorectal cancer and the tag pipeline.
- TrialTesting Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Shares Floxuridine, Oxaliplatin, Colorectal cancer and the tag pipeline.
- TrialA Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
Shares Oxaliplatin, Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialSafety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
Shares Oxaliplatin, Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialClinical Studies for the Treatment of Advanced Solid Tumors
Shares Oxaliplatin, Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.